ArticleCNS neuroscience & therapeutics2026
Association of the Triglyceride-Glucose (TyG) Index and TyG-BMI With 1-Year Outcomes Following Endovascular Treatment in Acute Basilar Artery Occlusion.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundLong-term outcomes after endovascular treatment (EVT) in acute basilar artery occlusion (BAO) vary substantially, yet metabolic correlates remain incompletely characterized. This study evaluated whether the triglyceride-glucose (TyG) index and TyG-body mass index (TyG-BMI) are associated with 1-year functional status and mortality after EVT.
methodsA single-center registry with prospective data collection was retrospectively analyzed. Consecutive acute BAO patients undergoing EVT within 24 h (December 2012-September 2024) were included. Unfavorable functional outcome at 1 year was defined as modified Rankin Scale (mRS) 4-6; 1-year all-cause mortality was also assessed. Multivariable logistic regression was applied, with receiver operating characteristic analyses and prespecified subgroup analyses.
resultsThe final cohort comprised 298 patients (median age 62 years; 78.5% male), among whom 165 (55.4%) had an unfavorable 1-year outcome and 109 (36.6%) died. After adjustment, each 1-SD increase in TyG and TyG-BMI corresponded to higher odds of unfavorable outcome (TyG OR 1.69, 95% CI 1.25-2.30; TyG-BMI OR 1.46, 95% CI 1.10-1.96) as well as mortality (TyG OR 1.44, 95% CI 1.09-1.90; TyG-BMI OR 1.61, 95% CI 1.23-2.12). Discrimination was modest and similar between indices. A significant sex interaction was observed for TyG-BMI and mortality (p for interaction = 0.03), with an association in men only.
conclusionsIn EVT-treated acute BAO, TyG and TyG-BMI may help identify EVT-treated acute BAO patients at higher risk of poor 1-year outcome and death. The mortality risk associated with TyG-BMI was modified by sex, with an effect confined to men.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.